Plasma Pentraxin3 is a Novel Marker for Nonalcoholic Steatohepatitis (NASH)

BACKGROUND: The changes in the liver in nonalcoholic fatty liver disease (NAFLD) range over a wide spectrum, extending from steatosis to steatohepatitis (NASH). However it has remained difficult to differentiate between NASH and non-progressive NAFLD on the basis of the clinical findings alone. AIMS...

Descripción completa

Detalles Bibliográficos
Autores principales: Yoneda, Masato, Uchiyama, Takashi, Kato, Shingo, Endo, Hiroki, Fujita, Koji, Yoneda, Kyoko, Mawatari, Hironori, Iida, Hiroshi, Takahashi, Hirokazu, Kirikoshi, Hiroyuki, Inamori, Masahiko, Nozaki, Yuichi, Kobayashi, Noritoshi, Kubota, Kensuke, Saito, Satoru, Maeyama, Shiro, Sagara, Mina, Aburatani, Hiroyuki, Kodama, Tatsuhiko, Nakajima, Atsushi
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2008
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2621235/
https://www.ncbi.nlm.nih.gov/pubmed/19014569
http://dx.doi.org/10.1186/1471-230X-8-53

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2621235/
https://www.ncbi.nlm.nih.gov/pubmed/19014569
http://dx.doi.org/10.1186/1471-230X-8-53

Ejemplares similares